Tel :
05 55 05 69 83
Courriel :
secretariat.cic@chu-limoges.fr
Adresse
2 Av. Martin Luther King, Limoges

Publication et diffusion des connaissances 2018

Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial

RJ LEWIS, DC ANGUS, PF LATERRE, AL KJØLBYE, E VAN DER MEULEN, A BLEMINGS, T GRAVES, JA RUSSELL, JE CARLSEN, K JACOBSEN, DM YEALY, SM OPAL, NA WINDELØV, B FRANÇOIS , A PERNER, P PICKKERS, BERRY SM

Ann Am Thorac Soc. février 2018 ; 15(2):250-257
IF:4,006
Limited value of end-expiratory inferior vena cava diameter to predict fluid responsiveness. Impact of intra-abdominal pressure.

A VIEILLARD-BARON, B EVRARD, X REPESSE, J MAIZEL, C JACOB, M GOUDELIN, C CHARRON, G PRAT, M SLAMA, G GERI, P VIGNON

Intensive Care Med. février 2018 ; 44(2):197-203
IF:15,008
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial

B FRANCOIS, R JEANNET, T DAIX, AH WALTON, MS SHOTWELL, J UNSINGER, G MONNERET, T RIMMELÉ, T BLOOD, M MORRE, A GREGOIRE, GA MAYO, J BLOOD, SK DURUM, ER SHERWOOD, RS HOTCHKISS.

JCI Insight. mars 2018 ; 3(5):e98960
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock

D ANNANE, A RENAULT, C BRUN-BUISSON, B MEGARBANE, JP QUENOT, S SIAMI, A CARIOU, X FORCEVILLE, C SCHWEBEL, C MARTIN, JF TIMSIT, B MISSET, M ALI BENALI, G COLIN, B SOUWEINE, K ASEHNOUNE, E MERCIER, L CHIMOT, C CHARPENTIER, B FRANÇOIS, T BOULAIN, F PETITPAS, JM CONSTANTIN, G DHONNEUR, F BAUDIN, A COMBES, J BOHÉ, JF LORIFERNE, R AMATHIEU, F COOK, M SLAMA, O LEROY, G CAPELLIER, A DARGENT, T HISSEM, V MAXIME, E BELLISSANT; CRICS-TRIGGERSEP Network

N Engl J Med. mars 2018 ; 378(9):809-818
IF:79,260
Hemodynamic Assessment of Patients With Septic Shock Using Transpulmonary Thermodilution and Critical Care Echocardiography: A Comparative Study.

P VIGNON, E BEGOT, A MARI, S SILVA, L CHIMOT, P DELOUR, F VARGAS, B FILLOUX, D VANDROUX, J JABOT, B FRANCOIS, N PICHON, M CLAVEL, B LEVY, M SLAMA, B RIU-POULENC.

Chest. 2018 ; 153(1) : 55-64
IF:7,652
Real-time three-dimensional transesophageal echocardiography fails discriminating between infectious vegetation and artefact

M GOUDELIN, A HERNANDEZ PADILLA, C GONZALEZ, P VIGNON

Intensive Care Med .. 2018 ; 44(6):992-994
IF:15,008
Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction.

B LEVY, R CLERE-JEHL, A LEGRAS, T MORICHAU-BEAUCHANT, M LEONE, F GANSTER, JP QUENOT, A KIMMOUN, J LASSUS, VP HARJOLA, F MEZIANI, G LOUIS, N GIRERD, K DUARTE, A MEBAZAA, P VIGNON

J Am Coll Cardiol . 2018 ; 72(2):173-182
IF:16,834
Diagnostic capability of a next-generation ultra-miniaturized ultrasound system in patients with cardiopulmonary compromise assessed using basic critical care echocardiography

M GOUDELIN, B EVRARD, F DALMAY, A HERNANDEZ PADILLA, C GONZALEZ, T LAFON, T DAIX, AL FEDOU, B FRANCOIS, P VIGNON.

Intensive Care Med . 2018 ; 44(9):1579-1581
IF:15,008
Acceleration of the learning curve for mastering basic critical care echocardiography using computerized simulation

P VIGNON, B PEGOT, F DALMAY, V JEAN-MICHEL, S BOCHER, E L’HER, J CROS, G PRAT

Intensive Care Med. 2018 ; 44(7):1097-1105
IF:15,008
Multicentric standardized flow cytometry routine assessment of septic patient to predict clinical worsening

T DAIX, E GUERIN, E TAVERNIER, E MERCIER, V GISSOT, O HERAULT, JP MIRA, F DUMAS, N CHAPUIS, C GUITTON, MC BENE, JP QUENOT, C TISSIER, J GUY, G PITON, A ROGGY, G MULLER, E LEGAC, N DE PROST, M KHELLAF, O WAGNER-BALLON, R COUDROY, E DINDINAUD, F UHEL, M ROUSSEL, T LAFON, R JEANNET, F VARGAS, C FLEUREAU, M ROUX, K ALLOU, P VIGNON, J FEUILLARD, B FRANCOIS.

Chest . septembre 2018 ; 154(3):617-627
IF:7,652
Validation du score qSOFA au service d’acceuil des urgences : étude prospective monocentrique

T LAFON, C VALLEJO, A ORGANISTA, A BAISSE, C ZMIRI, L COROLLER, G MOREL, T DAIX, B FRANCOIS, P VIGNON

Ann Fr Med Urgence . 2018 ; 8:165-171
IF:
Immature Granulocytes, a risk factor of infection after cardiac surgery

T DAIX, E GUERIN, E TAVERNIER, JP MARSAUD, A HACAND, F GAUTIER, A PICCARDO, P VIGNON, J FEUILLARD, B FRANCOIS

Cytometry B Clin Cytom. novembre 2018 ; 94(6):887-894
IF:2,757
Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP).

JL VINCENT, JY LEFRANT, K KOTFIS, R NANCHAL, I MARTIN-LOECHES, X WITTEBOLE, SG SAKKA, P PICKKERS, R MORENO, Y SAKR; ICON AND SOAP INVESTIGATORS; SOAP INVESTIGATORS

Intensive Care Med. mars 2018 ; 44(3):337-344
IF:15,008
A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations audit.

E PETERS, M ANTONELLI, X WITTEBOLE, R NANCHAL, B FRANÇOIS, Y SAKR, JL VINCENT, P PICKKERS

Crit Care. aout 2018 ; 22(1):188
IF:6,425
Misuse and adverse effects of new direct oral anticoagulants: A prospective observational study in patients admitted to an emergency unit of a French university hospital

T LAFON, C VALLEJO, M HADJ, ML LAROCHE, H GENIAUX

Therapie. mai 2018 ; 73(3):209-215
IF:1,524
New molecular semi-quantification tool provides reliable microbiological evidence for pulmonary infection

J YUGUEROS-MARCOS, O BARRAUD, A IANNELLO, MC PLOY, C GINOCCHIO M, ROGATCHEVA, C ALBERTI-SEGUI, A PACHOT, V MOUCADEL, B FRANÇOIS; VALIBI study group

Intensive Care Med. décembre 2018 ; 44(12):2302-2304
IF:15,008
Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial

B FRANÇOIS, E MERCIER, C GONZALEZ, K ASEHNOUNE, S NSEIR, M FIANCETTE, A DESACHY, G PLANTEFÈVE, F MEZIANI, PA DE LAME, PF LATERRE; MASTER 1 study group

Intensive Care Med . novembre 2018 ; 44(11):1787-1796
IF:15,008
Multi-centre evaluation of recent troponin assays for the diagnosis of NSTEMI

C CHENEVIER-GOBEAUX, L DEWEERDT, AV CANTERO, B RENAUD, B DESMAIZIÈRES, S CHARPENTIER, A LEROY, E ADELAÏDE, D COLLIN-CHAVAGNAC, E BONNEFOY-CUDRAZ, L ESTEPA, A CHEKROUNE, S BASCO, S ANDRIEU, S BOURGEOIS, MA COSTA, C VALLEJO, T ROBERT, S OUAHABI, B BAUDIN, B BENETEAU-BURNAT, AM GORCE-DUPUY, P RAY, C GAST, M DEHOUX, G LEFÈVRE; Troponins Working Group of the Société Française de Biologie Clinique (SFBC), in collaboration with the Société Française de Médecine d′Urgence (SFMU) and the Société Française de Cardiologie (SFC)

Pract Lab Med. février 2018 ; 11:23-32
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study

A MEBAZAA, C GEVEN, A HOLLINGER, X WITTEBOLE, BG CHOUSTERMAN, A BLET, E GAYAT, O HARTMANN, P SCIGALLA, J STRUCK, A BERGMANN, M ANTONELLI, A BEISHUIZEN, JM CONSTANTIN, C DAMOISEL, N DEYE, S DI SOMMA, T DUGERNIER, B FRANÇOIS, S GAUDRY, V HUBERLANT, JB LASCARROU, G MARX, E MERCIER, H OUESLATI, P PICKKERS, R SONNEVILLE, M LEGRAND, PF LATERRE; AdrenOSS-1 study investigators

Crit Care . décembre 2018 ; 22(1):354
IF:6,425
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results

T APARICIO, O BOUCHÉ, J TAIEB, E MAILLARD, S KIRSCHER, PL ETIENNE, R FAROUX, F KHEMISSA AKOUZ, F EL HAJBI, C LOCHER, Y RINALDI, T LECOMTE, S LAVAU-DENES, M BACONNIER, A ODEN-GANGLOFF, D GENET, E PAILLAUD, F RETORNAZ, E FRANÇOIS, L BEDENNE; for PRODIGE 20 Investigators

Ann Oncol . janvier 2018 ; 29(1):133-138
IF:13,930
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer

T APARICIO, O BOUCHÉ, E FRANCOIS, F RETORNAZ, E BARBIER, J TAIEB, S KIRSCHER, PL ETIENNE, R FAROUX, F KHEMISSA AKOUZ, F EL HAJBI, C LOCHER, Y RINALDI, T LECOMTE, S LAVAU-DENES, M BACONNIER, A ODEN-GANGLOFF, D GENET, L E BEDENNE, PAILLAUD; for PRODIGE 20 investigators

Eur J Cancer. juillet 2018 ; 97:16-24
IF:7,191
Human papillomavirus detection in gargles, tonsil brushings, and frozen tissues in cancer-free patients

JD COMBES, C CLAVEL, V DALSTEIN, T GHEIT, GM CLIFFORD, M TOMMASINO, S FRANCESCHI, J LACAU ST GUILY; SPLIT study group

Oral Oncol. juillet 2018 ; 82:34-36
IF:4,636
Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9)

T APARICIO, F GHIRINGHELLI, V BOIGE, K LE MALICOT, J TAIEB, O BOUCHÉ, JM PHELIP, E FRANÇOIS, C BOREL, R FAROUX, L DAHAN, S JACQUOT, D GENET, F KHEMISSA, E SUC, F DESSEIGNE, P TEXEREAU, C LEPAGE, J BENNOUNA; PRODIGE 9 Investigators

J Clin Oncol. mars 2018 ; 36(7):674-681
IF:26,360
Prevalence and risk factors of human polyomavirus infections in non-malignant tonsils and gargles: the SPLIT study

A KOURIEH, JD COMBES, M TOMMASINO, V DALSTEIN, GM CLIFFORD, J LACAU ST GUILY, C CLAVEL, S FRANCESCHI, T GHEIT, For The SPLIT Study Group

J Gen Virol. décembre 2018 ; 99(12):1686-1698
IF:2,514
Prevalence of human herpesviruses infections in nonmalignant tonsils: The SPLIT study

A KOURIEH, T GHEIT, M TOMMASINO, V DALSTEIN, GM CLIFFORD, J LACAU ST GUILY, C CLAVEL, S FRANCESCHI, JD COMBES; SPLIT study group

J Med Virol . octobre 2018 ; 91(4):687-697
IF:1,988
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome

A BOUMEDIENE, P VACHIN, K SENDEYO, J ONISZCZUK, SY ZHANG, C HENIQUE, A PAWLAK, V AUDARD, M OLLERO, V GUIGONIS, D SAHALI

J Autoimmun. mars 2018 ; 88:91-102
IF:7,607

Publications 2018

Réalisées en collaboration avec les équipes associées du CIC.


20172019 2020